A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Efavirenz; Fosamprenavir; Lamivudine/abacavir; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms SUPPoRT
- 15 Oct 2011 Results presented at the 13th European AIDS Conference.
- 14 Oct 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 14 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History